Aggregation System Improves Analysis of Sub-Visible Particles - - BioPharm International

ADVERTISEMENT

Aggregation System Improves Analysis of Sub-Visible Particles


BioPharm International
Volume 27, Issue 4, pp. 40-42

Shimadzu introduces the Aggregates Sizer Aggregation Analysis System, which provides real-time quantitative evaluation of 100 nm to 10 μm sub-visible particle (SVP) aggregates. By screening and identifying aggregation-prone proteins in early-stage drug development, manufacturers can save time and reduce costs.

The Aggregates Sizer is capable of identifying all ranges of SVP particles from invisible to visible, in a single measurement in micro-sample quantities as small as 0.4 mL. It also enables quantitative evaluation of the concentration of those aggregates.

In addition, the Aggregates Sizer can execute ongoing measurements in intervals as short as one second, allowing users to evaluate rates of change at intermediate stages during the manufacturing process. A batch cell (5 mL sample capacity) enables observation of aggregation processes as samples are mechanically stimulated. This helps prevent the formation of aggregates during drug manufacturing and improves testing without the need for additional equipment.

Shimadzu Scientific Instruments

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here